Therapy of Inflammatory Bowel Disease: What to Expect in the Next Decade

David A. Leiman; Gary R. Lichtenstein


Curr Opin Gastroenterol 

In This Article


The future holds potential for new and effective therapies for patients with IBD. Multiple agents acting via novel mechanisms are being explored and developed to increase our existing therapeutic armamentarium. It is likely that the next decade will see some of these drugs come to market. As we gain a greater understanding of the microbiome and its role in the pathogenesis of IBD, there will be many new opportunities for even more options, including antibiotics, fecal transplant, probiotics, and nonimmunosuppressive agents.